Cyltezo Interactions
There are 551 drugs known to interact with Cyltezo (adalimumab), along with 8 disease interactions. Of the total drug interactions, 300 are major, 242 are moderate, and 9 are minor.
- View all 551 medications that may interact with Cyltezo
- View Cyltezo disease interactions (8)
Most frequently checked interactions
View interaction reports for Cyltezo (adalimumab) and the medicines listed below.
- Advair HFA (fluticasone / salmeterol)
- Afinitor (everolimus)
- Afrin Original (oxymetazoline nasal)
- Aleve (naproxen)
- amlodipine
- ashwaganda
- Aspir 81 (aspirin)
- azathioprine
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Baraclude (entecavir)
- Bariatric Multivitamins with 45 mg Iron (multivitamin with minerals)
- Bayer Aspirin (aspirin)
- Benadryl Allergy (diphenhydramine)
- benzonatate
- biotin
- Breo Ellipta (fluticasone / vilanterol)
- bupropion
- buspirone
- chamomile
- Chantix (varenicline)
- Cimzia (certolizumab)
- Claritin (loratadine)
- hydroxyzine
- lisinopril
- omeprazole
- Remicade (infliximab)
- Stelara (ustekinumab)
- sulfasalazine
- trazodone
- Vitamin D3 (cholecalciferol)
Cyltezo disease interactions
There are 8 disease interactions with Cyltezo (adalimumab) which include:
- infections
- malignancies
- neurologic reactions
- tuberculosis
- CHF
- COPD
- hematologic abnormalities
- hepatitis B
Report options
QR code containing a link to this page
More about Cyltezo (adalimumab)
- Cyltezo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
